Manufacturing

Compressed tablets are the most widely used solid dosage form so they must satisfy a number of physical requirements in terms of hardness, disintegration ability, friability and uniformity.

One-pot processing is a term that includes any technology that combines different unit operations of a pharmaceutical production process into one machine.

The author presents a method to calculate the relationship between supply air volume flow and airborne particle concentrations.

Moisture Activated Dry Granulation (MADG) was developed in response to the difficulties experienced with wet granulation, in terms of endpoint, drying and milling. Wet granulation process endpoint is very sensitive to granulation time and shear. The wet granules need to be dried to a narrow range of moisture contents, which is difficult. The dried granules need to be milled, but the milled granules often have either too many fines or too many coarse particles (or both) - an undesirable bimodal distribution.

In France, public confidence in health authorities and pharmaceutical industry has been shaken by a safety scandal over the drug Mediator (benfluorex hydrochloride).

The unit selected for wet granulation, whether it be a high shear mixer or a fluidised bed, has a marked impact on granule properties.

Although tablet manufacture is traditionally a batchbased wet granulation process, there are many advantages to be gained by adopting dry granulation, including lower costs and increased yields.

Tooling standardisation in the tablet manufacturing industry is a topic that has concerned tabletting professionals for decades.

Fujifilm and Merck & Co. have formed a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a contract biopharmaceutical manufacturing and development business of Merck.

Pfizer Completes King Acquisition; ViiV Healthcare Names Chairman; and More.

FDA recently sent sanofi-aventis two Warning Letters for its facilities in Frankfurt am Main, Germany, and Bridgewater, NJ.

With a regulatory pathway for follow-on biologics, industry is wondering what FDA will do next.

The 2011 show presents ideas for package designs and equipment options for packaging lines.

New product reviews from March 2011.

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.

The authors evaluated the manufacturing data of 40-mg tablets of furosemide, a potent diuretic.

A revised book on process analytical technology could be valuable to novices and experts.

Brazil develops its first national plasma fractionation plant.

The authors investigated the tableting properties of PanExcea MHC300G, a high-performance excipient.

A single, global tooling standard would offer many benefits, but one has been slow to emerge.

The author describes key considerations for drug manufacturers when evaluating packaging partners.

Q&A with Robert Hardy, chief executive of Aesica

Social media tools have taken over many aspects of our lives, now including regulatory info.

The author provides an overview of QbD implmentation for biopharmaceuticals.

Just when things seem to be looking up, the unexpected problem occurs.

The authors review a compliance-by-design approach to quality systems.

Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and type of spending made in 2010 and planned for 2011.

The author challenges current detection methodologies.

As drug shortages make headlines, FDA tests the Sentinel safety system and its efect on healthcare.

This report provides plans for the USP Council's work in the 2010-2015. This articles contains online bonus material.